Nifty

:

23622.90

Sensex

:

75527.95

461.30 (1.99%)
1695.40 (2.30%)

Login

Nifty
Sensex

:
:

23622.90
75527.95

461.30 (1.99%)
1695.40 (2.30%)

Samrat Pharmachem Ltd.

Pharmaceuticals & Drugs

Rating :

52/99

BSE: 530125 | NSE: Not Listed

Watchlist

NSE BSE

200.75

12-Jun-2026

Open
High
Low
Previous Close

205.1
209.7
199.05
200.15

Volume
Traded Value (lacs)
52 Week High
52 Week Low

2053
418950
209.7
0

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

62.03
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

66.74
N/A
0.91

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

16.29
9.81
-2.73

EBITDA CAGR (%)

10 Years
5 Years
3 Years

23.91
3.38
-15.61

PAT CAGR (%)

10 Years
5 Years
3 Years

37.24
5.93
-24.67

P:E (Median)

8 Years
5 Years
3 Years

11.61
12.88
16.36

P:BV (Average)

8 Years
5 Years
3 Years

2.09
2.26
1.61

EV:EBITDA (Average)

8 Years
5 Years
3 Years

20.37
28.71
42.90

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 71.77 71.20 0.80% 63.43 63.66 -0.36% 78.87 70.17 12.40% 75.65 80.82 -6.40%
Expenses 73.02 71.08 2.73% 64.08 59.49 7.72% 79.23 66.81 18.59% 75.53 78.24 -3.46%
EBITDA -1.25 0.13 - -0.66 4.17 - -0.36 3.36 - 0.13 2.58 -94.96%
EBIDTM -1.73% 0.18% -1.04% 6.55% -0.46% 4.79% 0.17% 3.20%
Other Income -0.31 -0.11 - 0.40 0.00 0 0.05 0.49 -89.80% 0.69 0.59 16.95%
Interest 0.14 0.22 -36.36% 0.13 0.10 30.00% 0.26 0.16 62.50% 0.44 0.19 131.58%
Depreciation 0.19 0.16 18.75% 0.19 0.17 11.76% 0.18 0.17 5.88% 0.17 0.16 6.25%
PBT -1.88 -0.36 - -0.57 3.91 - -0.75 3.52 - 0.21 2.82 -92.55%
Tax 0.16 0.04 300.00% -0.11 1.13 - -0.16 0.86 - 0.44 0.75 -41.33%
PAT -2.04 -0.40 - -0.46 2.79 - -0.59 2.66 - -0.23 2.07 -
PATM -2.84% -0.56% -0.73% 4.37% -0.75% 3.79% -0.30% 2.56%
EPS -6.57 -1.29 - -1.48 8.98 - -1.90 8.58 - -0.74 6.66 -

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 289.72 285.86 281.58 310.65 221.75 179.02 137.45 111.14 92.94 72.75 63.20 Net Sales Growth 1.35% 1.52% -9.36% 40.09% 23.87% 30.24% 23.67% 19.58% 27.75% 15.11% Cost Of Goods Sold 283.05 266.75 270.32 277.86 189.90 164.25 125.62 102.61 81.60 62.78 56.32 Gross Profit 6.67 19.11 11.26 32.78 31.85 14.77 11.84 8.52 11.34 9.97 6.88 GP Margin 2.30% 6.69% 4.00% 10.55% 14.36% 8.25% 8.61% 7.67% 12.20% 13.70% 10.89% Total Expenditure 291.86 275.62 279.13 286.72 197.51 170.35 130.82 107.96 86.99 69.07 62.00 Power & Fuel Cost - 1.39 1.37 1.46 1.34 1.12 0.91 0.73 0.82 0.66 0.74 % Of Sales - 0.49% 0.49% 0.47% 0.60% 0.63% 0.66% 0.66% 0.88% 0.91% 1.17% Employee Cost - 1.11 1.11 1.07 0.96 1.05 1.00 0.94 0.85 0.76 0.66 % Of Sales - 0.39% 0.39% 0.34% 0.43% 0.59% 0.73% 0.85% 0.91% 1.04% 1.04% Manufacturing Exp. - 2.39 2.17 2.51 2.38 1.71 1.28 1.46 1.31 1.50 1.20 % Of Sales - 0.84% 0.77% 0.81% 1.07% 0.96% 0.93% 1.31% 1.41% 2.06% 1.90% General & Admin Exp. - 2.64 2.55 2.11 1.73 1.11 1.17 1.20 1.10 0.93 0.87 % Of Sales - 0.92% 0.91% 0.68% 0.78% 0.62% 0.85% 1.08% 1.18% 1.28% 1.38% Selling & Distn. Exp. - 0.91 1.25 1.43 1.02 0.79 0.75 1.01 1.30 2.27 2.21 % Of Sales - 0.32% 0.44% 0.46% 0.46% 0.44% 0.55% 0.91% 1.40% 3.12% 3.50% Miscellaneous Exp. - 0.43 0.37 0.27 0.18 0.32 0.09 0.01 0.01 0.15 2.21 % Of Sales - 0.15% 0.13% 0.09% 0.08% 0.18% 0.07% 0.01% 0.01% 0.21% 0% EBITDA -2.14 10.24 2.45 23.93 24.24 8.67 6.63 3.18 5.95 3.68 1.20 EBITDA Margin -0.74% 3.58% 0.87% 7.70% 10.93% 4.84% 4.82% 2.86% 6.40% 5.06% 1.90% Other Income 0.83 0.98 1.40 0.48 0.63 0.46 0.57 0.46 0.25 0.16 0.21 Interest 0.97 0.67 0.69 1.23 0.67 1.28 0.98 1.06 0.86 0.63 0.51 Depreciation 0.73 0.65 0.65 0.64 0.59 0.49 0.43 0.42 0.41 0.43 0.44 PBT -2.99 9.89 2.52 22.53 23.60 7.36 5.80 2.16 4.92 2.78 0.45 Tax 0.33 2.77 0.36 5.90 6.42 2.01 1.55 0.62 1.70 1.02 0.15 Tax Rate -11.04% 28.01% 14.29% 26.19% 27.20% 27.38% 26.77% 28.70% 34.55% 36.69% 33.33% PAT -3.32 7.11 2.16 16.63 17.18 5.33 4.24 1.54 3.22 1.75 0.30 PAT before Minority Interest -3.32 7.11 2.16 16.63 17.18 5.33 4.24 1.54 3.22 1.75 0.30 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -1.15% 2.49% 0.77% 5.35% 7.75% 2.98% 3.08% 1.39% 3.46% 2.41% 0.47% PAT Growth -146.63% 229.17% -87.01% -3.20% 222.33% 25.71% 175.32% -52.17% 84.00% 483.33% EPS -10.71 22.94 6.97 53.65 55.42 17.19 13.68 4.97 10.39 5.65 0.97

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 71.80 65.00 63.14 46.82 29.64 24.30 20.07 18.53 15.31 13.76 Share Capital 3.09 3.09 3.09 3.09 3.09 3.09 3.09 3.09 3.09 3.09 Total Reserves 68.71 61.91 60.05 43.73 26.55 21.21 16.98 15.44 12.22 10.67 Non-Current Liabilities 0.11 0.34 0.25 0.46 0.43 0.14 0.83 1.27 1.66 1.96 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.31 0.76 1.17 1.53 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 49.58 56.40 53.19 37.33 27.33 33.90 19.33 21.02 19.10 20.46 Trade Payables 38.56 47.67 31.88 23.39 17.66 23.15 12.66 10.40 7.30 16.09 Other Current Liabilities 0.14 0.28 0.52 0.89 0.17 0.44 0.53 1.00 5.79 0.57 Short Term Borrowings 9.91 8.45 18.66 7.52 8.79 9.10 5.77 8.22 5.42 3.70 Short Term Provisions 0.97 0.00 2.14 5.53 0.70 1.22 0.37 1.41 0.60 0.10 Total Liabilities 121.49 121.74 116.58 84.61 57.40 58.34 40.23 40.82 36.07 36.18 Net Block 10.48 10.72 10.70 9.99 9.40 7.19 6.86 6.99 7.01 7.28 Gross Block 16.85 16.62 16.25 14.89 14.00 11.44 10.92 10.62 10.24 9.81 Accumulated Depreciation 6.37 5.89 5.55 4.91 4.60 4.25 4.05 3.63 3.22 2.53 Non Current Assets 18.13 19.17 17.54 13.35 10.07 8.67 7.47 7.56 7.79 7.81 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 1.08 0.00 0.00 0.20 0.00 Non Current Investment 3.44 2.92 1.86 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 0.75 1.47 0.91 0.80 0.65 0.40 0.51 0.49 0.51 0.44 Other Non Current Assets 3.46 4.06 4.06 2.56 0.02 0.00 0.10 0.08 0.06 0.08 Current Assets 103.36 102.57 99.05 71.26 47.32 49.68 32.76 33.27 28.30 28.37 Current Investments 0.36 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 2.00 Inventories 38.01 20.68 32.53 12.42 11.40 18.77 7.93 6.85 7.02 5.68 Sundry Debtors 56.54 69.28 51.67 43.57 33.01 27.81 21.05 21.89 11.84 16.10 Cash & Bank 0.16 9.73 11.89 14.71 2.51 1.17 2.25 3.98 2.44 3.50 Other Current Assets 8.30 0.07 0.06 0.07 0.41 1.93 1.53 0.55 7.00 1.09 Short Term Loans & Adv. 8.11 2.80 2.88 0.49 0.03 1.10 0.02 0.07 0.07 0.25 Net Current Assets 53.78 46.16 45.86 33.93 20.00 15.78 13.43 12.24 9.19 7.90 Total Assets 121.49 121.74 116.59 84.61 57.39 58.35 40.23 40.83 36.09 36.18

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity -10.09 9.41 -9.44 17.47 4.80 -1.33 2.37 0.13 -3.23 -0.36 PBT 9.89 2.52 22.53 23.60 7.34 5.79 2.16 4.92 2.78 0.45 Adjustment 0.65 0.03 1.65 1.19 1.70 1.39 1.40 1.17 1.12 0.83 Changes in Working Capital -19.17 9.83 -24.12 -5.78 -1.99 -7.62 0.47 -5.08 -6.57 -1.07 Cash after chg. in Working capital -8.64 12.38 0.06 19.01 7.05 -0.45 4.03 1.01 -2.68 0.21 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.51 Tax Paid -1.45 -2.97 -9.50 -1.53 -2.25 -0.87 -1.65 -0.88 -0.55 -0.06 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 0.00 -0.41 -3.00 -1.06 -2.92 -1.92 2.18 -2.44 1.23 -2.38 Net Fixed Assets -0.23 -0.37 -1.36 -0.89 -1.48 -1.60 -0.30 -0.18 -0.63 -0.41 Net Investments -0.87 -1.06 -1.86 -0.01 0.00 0.00 0.00 0.00 2.00 -2.00 Others 1.10 1.02 0.22 -0.16 -1.44 -0.32 2.48 -2.26 -0.14 0.03 Cash from Financing Activity 0.48 -11.20 9.60 -1.95 -1.89 2.00 -3.92 1.53 0.72 2.30 Net Cash Inflow / Outflow -9.62 -2.19 -2.84 14.46 -0.02 -1.25 0.63 -0.78 -1.28 -0.44 Opening Cash & Equivalents 9.67 11.86 14.71 0.24 0.26 1.50 0.87 1.65 2.93 3.94 Closing Cash & Equivalent 0.05 9.67 11.86 14.71 0.24 0.26 1.50 0.87 1.65 3.50

Financial Ratios

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 232.39 210.37 204.37 151.54 95.92 78.66 64.95 59.98 49.57 44.52 ROA 5.85% 1.81% 16.53% 24.20% 9.22% 8.60% 3.79% 8.37% 4.86% 0.97% ROE 10.40% 3.38% 30.25% 44.95% 19.77% 19.10% 7.96% 19.01% 12.07% 2.21% ROCE 13.61% 4.13% 34.91% 52.33% 23.90% 22.43% 11.80% 23.05% 16.40% 5.31% Fixed Asset Turnover 17.08 17.13 19.95 15.35 16.07 14.06 11.64 10.10 7.84 7.11 Receivable days 80.32 78.39 55.96 63.02 54.31 56.75 62.50 58.43 64.90 68.75 Inventory Days 37.46 34.48 26.40 19.60 26.94 31.01 21.51 24.02 29.49 27.12 Payable days 59.00 53.71 36.30 39.45 45.34 52.01 38.75 36.89 61.12 73.14 Cash Conversion Cycle 58.79 59.17 46.06 43.17 35.91 35.75 45.27 45.57 33.27 22.73 Total Debt/Equity 0.14 0.13 0.30 0.16 0.30 0.39 0.33 0.51 0.45 0.40 Interest Cover 15.67 4.67 19.29 35.99 6.75 6.91 3.04 6.70 5.37 1.88

Top Investors:

lloyds securities overseas limited

anshul specialty molecules

lalit kumar v jain

sharad kanayalal shah

Annual Reports:

News Update:

No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback